von Eyben, R. Et Al. 2023. Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer. Biomedicines , vol.11, no.9 .

von Eyben, R., Hoffmann, M. A., SOYDAL, Ç., Virgolini, I., TUNCEL, M., Gauthé, M., ... Kapp, D. S.(2023). Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer. Biomedicines , vol.11, no.9.

von Eyben, Rie Et Al. "Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer," Biomedicines , vol.11, no.9, 2023

von Eyben, Rie v. Et Al. "Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer." Biomedicines , vol.11, no.9, 2023

von Eyben, R. Et Al. (2023) . "Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer." Biomedicines , vol.11, no.9.

@article{article, author={Rie von Eyben Et Al. }, title={Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer}, journal={Biomedicines}, year=2023}